Table 4.
Subgroup analysis of outcomes limited to major pancreatectomy.
| All patients (190) | No cell saver (169) | Cell saver (21) | P | |
|---|---|---|---|---|
| Estimated blood loss (ml)a | 1028±95 | 941±95 | 1760±371 | 0.008 |
| % of blood loss returneda | n/a | 0±0 | 22±3.6 | n/a |
| Tolerance breached, n (%) | 44 (23.2) | 34 (20.0) | 10 (47.6) | 0.01 |
| Breach corrected for blood returned, n (%) | 0 (0) | 2 (20) | n/a | |
| Patients requiring allogenic transfusion | ||||
| PRC | 63 (33.1) | 53 (31.4) | 10 (47.6) | 0.2 |
| FFP | 10 (5.2) | 8 (4.7) | 2 (9.5) | 0.3 |
| Plt | 5 (2.6) | 4 (2.4) | 1 (4.8) | 0.4 |
| Total allogenic units transfused | ||||
| PRC | 277 | 236 | 41 | |
| FFP | 70 | 60 | 10 | |
| Plt | 14 | 12 | 2 | n/a |
| Allogenic PRC units per patienta | 1.5±0.2 | 1.4±0.2 | 2.1±0.8 | 0.4 |
| Allogenic FFP units per patienta | 0.4±0.1 | 0.4±0.2 | 0.5±0.4 | 0.8 |
| Allogenic Plt units per patienta | 0.07±0.04 | 0.07±0.04 | 0.1±0.1 | 0.8 |
| Hospital stay (days)b | 12 (9–18) | 12 (9–18) | 12 (7–20) | 0.8 |
| Major complication, n (%) | 21 (11.0) | 17 (10.0) | 4 (19.0) | 0.8 |
| Intervention for postoperative bleeding, n (%) | 4 (2.1) | 2 (1.1) | 2 (9.5) | 0.06 |
| 30-day mortality, n (%) | 1 (0.5) | 1 (0.6) | 0 (0) | 1.0 |
| 90-day mortality, n (%) | 2 (1.1) | 2 (1.2) | 0 (0) | 1.0 |
Statistically significant P <0.05 values are in bold.
a
Mean±Standard Error of the Mean.
b
median (Inter-Quartile Range).
FFP, fresh-frozen plasma; Plt, platelets; PRC, packed red cells.